D
Virax Biolabs Group Limited VRAX
$0.7412 -$0.0239-3.12% NASDAQ
Recommendation
Prev Close
$0.775
Volume
19,318
Avg Vol (90D)
135,658
Market Cap
$3.37M
Dividend & Yield
--
52-Week Range
$0.7222 - $7.63
P/E (TTM)
--
EPS (TTM)
-$1.65
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
7/29/2025 - GuruFocus
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial ...
7/29/2025 - GuruFocus
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
7/29/2025 - PR Newswire
Virax Biolabs (VRAX) Faces Nasdaq Compliance Challenge VRAX Stock News
7/19/2025 - GuruFocus
Virax Biolabs receives noncompliance notice from Nasdaq
7/19/2025 - TipRanks Financial Blog
Virax Biolabs receives noncompliance notice from Nasdaq
7/19/2025 - The Fly
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
7/18/2025 - GuruFocus
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price ...
7/18/2025 - GuruFocus
Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule
7/18/2025 - Seeking Alpha - Healthcare
Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule
7/18/2025 - SeekingAlpha.com: All News
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
7/18/2025 - PR Newswire
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations
7/4/2025 - Simply Wall St
What's Driving the Market Sentiment Around Virax Biolabs Group?
6/30/2025 - Benzinga
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 55.9% in May
6/14/2025 - Ticker Report
Virax Biolabs Announces CFO Resignation and Transition
6/13/2025 - TipRanks Financial Blog
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 23.2% in May
6/3/2025 - Ticker Report
Virax Biolabs Group (NASDAQ:VRAX) Trading Up 2% - Here's Why
5/25/2025 - Ticker Report
Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Rises By 85.9%
4/29/2025 - Ticker Report
Virax Biolabs initiated with a Buy at H.C. Wainwright
3/31/2025 - TipRanks Financial Blog
Virax Biolabs initiated with bullish view at H.C. Wainwright, here's why
3/31/2025 - The Fly
Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in ...
3/18/2025 - GuruFocus
Virax Biolabs enrolls first patients in T-cell dysfunction study
3/18/2025 - The Fly
Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
3/18/2025 - PR Newswire
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th ...
3/13/2025 - GuruFocus
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
3/13/2025 - PR Newswire
Income Statement
Total Revenue (TTM)
$6.40K
EBITDA (TTM)
-$5.91M
EBIT (TTM)
-$6.16M
Net Income (TTM)
-$6.06M
Balance Sheet
Total Assets (Q)
$6.43M
Total Debt (Q)
$714.60K
Total Liabilities (Q)
$964.80K
Book Value Per Share (Q)
$1.31
Cash Flow
Cash from Operations (TTM)
-$4.56M
Cash from Investing (TTM)
-$603.80K
Cash from Financing (TTM)
$5.81M
Net Change in Cash (TTM)
$639.80K
Filings
Filing Date
Wednesday, July 2, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 18 and 22 (est)
Price History
Loading...
Beta
2.89
7-Day Total Return
-4.45%
30-Day Total Return
-16.73%
60-Day Total Return
-29.41%
90-Day Total Return
-33.23%
Year to Date Total Return
-66.46%
1-Year Total Return
-88.42%
2-Year Total Return
-79.41%
3-Year Total Return
-98.35%
5-Year Total Return
--
52-week Low
Aug 13, 2025 - $0.7222
52-week High
Aug 28, 2024 - $7.63
Valuation
Market Cap
$3.37M - Nano Cap
Enterprise Value
-$477.51K
Price/Sales (TTM)
553.57
Price/Book (Q)
0.59
Dividends and Shares
Shares Outstanding
4.36
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
viraxbiolabs.com
Phone Number
44 20 7788 7414
Address
BioCity Glasgow
Lanarkshire, ML1 5UH
Country
United Kingdom
Year Founded
2013
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in... more
NASDAQ 08/21/2025 3:39PM Eastern Quotes delayed